Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Malvern Instruments’ 2014 Webinar Program Gets Underway with Light Scattering
Tuesday, January 21, 2014
Malvern’s ‘Step into the Light’ webinar on 21 January.

Monash University Orders High End TEM for Integrated Structural Biology
Tuesday, September 10, 2013
World-class research facility will integrate cryo-EM with X-ray diffraction, nuclear magnetic resonance, synchrotron-based approaches and computational techniques to determine atomic structure and functional mechanisms of medically-important protein complexes.

Bruker Announces New ECO™ Line of XRD and XRF Instruments
Tuesday, July 23, 2013
Launch of S8 TIGER ECO™, the D8 ADVANCE ECO™ and the D8 QUEST ECO™ instruments.

Best Practices for Optimizing Particle Size Distributions
Thursday, May 23, 2013
New white paper to help meet the challenge of understanding, optimizing and controlling particle and droplet systems.

Advanced Seeding Techniques Optimize Crystallization Results
Wednesday, April 24, 2013
New technologies for crystallization development.

PANalytical Showcase Exceptional X-ray Technology at Pittcon 2013
Monday, March 18, 2013
Company will also showcase the Empyrean XRD system, the X’Pert Powder XRD system and the Axios WDXRF system.

EMBL Choose ambr Micro Bioreactor System for Insect Cell Culture
Friday, March 08, 2013
Enabling rapid production of human multi-protein complexes using baculovirus.

Rigaku Introduces New BioSAXS-1000 AUTO
Tuesday, February 19, 2013
The world’s most comprehensive biological SAXS system for the home lab.

Syrris’ Versatile Atlas Batch Reactor System Makes Polymerization Easier
Tuesday, January 22, 2013
Petroleum and petrochemical provider PTT is reaping the benefits of the Atlas lab scale chemistry reactor system from Syrris, simplifying the production of catalysts for polyolefins.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 233
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv